Is Healthpeak Properties profitable in 2026?

Yes. Healthpeak reported Q1 2026 revenue of $752.95 million, up 7.1% year over year, beating consensus of $694.59 million, with EPS of $0.45 versus $0.43 expected, as of May 5, 2026.

Could AI replace Healthpeak Properties' business?

No. Healthpeak owns physical real estate like hospital-affiliated medical buildings and lab campuses that AI cannot disintermediate. AI may only trim back-office finance and analytics roles; entitlements and tenant relationships remain untouched as of 2026.

Who is Healthpeak Properties' biggest competitor?

Welltower, with a market cap around $165.6 billion as of July 2026, dwarfs Healthpeak's $15.4 billion. Ventas (~$40.3 billion) is a closer strategic peer, and Alexandria competes directly in life science real estate.

Who owns Healthpeak Properties?

Healthpeak is fully public on the NYSE under ticker DOC, with no controlling parent. Institutional holders dominate, such as Vanguard Real Estate Index Fund at roughly 4.29% as of August 31, 2025; corporate insiders own only about 0.23%.

What happened to HCP Inc, the old name for Healthpeak?

HCP, Inc. renamed itself Healthpeak Properties and changed its ticker from HCP to PEAK in November 2019, then switched again to DOC in March 2024 after closing an all-stock merger with Physicians Realty Trust worth about $21 billion.

Is Healthpeak's life science real estate bet risky?

Yes, near-term. Healthpeak bought a $600 million South San Francisco lab campus in January 2026 at only 60% occupancy, while Bay Area lab vacancy sat at 39.8% in Q3 2025 and peer Alexandria posted a $234.9 million quarterly net loss.

Real estate developers · United States

Healthpeak Properties

healthpeak.com ↗

REIT that owns hospitals, medical offices and life-science labs, leasing space to healthcare operators.

Defensible for now

Assessed 24 July 2026 · Evidence as of 24 July 2026

Real protection, with named pressure against it.

On the recordSince 24 July 2026 · Checkable from August 4-5, 2026 · Every call on the record Checkpoint: Q2 2026 earnings release

The call

The buildings and leases are safe from AI and rivals alike, but Healthpeak's fresh bet on Bay Area life-science labs is landing into a market with roughly 40% vacancy.

Healthpeak Properties owns and leases out 700 buildings across the United States, mostly medical offices and laboratory spaces. The company makes money from long-term contracts with hospitals, doctors, and research companies that rent these buildings, and since physical buildings cannot be replaced by artificial intelligence or copied by competitors, the rent payments should keep flowing for years. However, Healthpeak is currently buying more laboratory buildings in the San Francisco Bay Area when those types of buildings are sitting half-empty and losing money for other companies, so the company itself will probably survive but its stock price could drop in the near term if too many lab tenants stay empty or move out.

Why

AI pressure: None apparent. AI can trim back-office finance headcount but cannot lease, replace or relocate a hospital building or lab campus. Could AI do the core job? Unlikely.

Bigger players: Welltower and Ventas. Both are bigger, cheaper-funded healthcare REITs bidding for the same senior housing and medical office deals Healthpeak wants. Could a giant copy it? Probably.

What protects it. Long-term leases and hard-to-replace locations (hospitals, medical campuses) mean existing rent checks keep coming regardless of who else is building.

What would change this call

Gateway Crossing South San Francisco occupancy change reported by year-end 2026. Shows whether Healthpeak's life-science pivot is filling space or losing tenants to rivals.
Bay Area lab vacancy rate reported for 2027. Confirms whether oversupply pressuring Healthpeak and Alexandria persists or eases.
Alexandria Real Estate quarterly NOI trend through 2026. Indicates whether the broader life-science leasing market is recovering or still weak.

Key numbers

Market cap ~$15.4 billion (2026-07-22)
Q1 2026 revenue $752.95M, up 7.1% YoY (2026-05-05)
Portfolio: ~700 properties, ~49 million sq ft (2026-07-07)

Named risks

Bay Area life science oversupply could keep new $600M South SF campus underoccupied past 2026. Severity: high
Refinancing $650 million of 3.5% notes at higher rates pressures 2H 2026 interest expense. Severity: medium
Sector-wide life science softness mirrored by Alexandria's declining NOI could extend to Healthpeak's lab segment. Severity: high
Janus Living spin-off execution risk affects Healthpeak's equity-method income and sponsor reputation. Severity: medium
AI-driven automation could reduce headcount needs in finance and leasing analytics functions. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Welltower	losing to	Welltower market cap ~$165.6B vs Healthpeak ~$15.4B as of July 2026, over 2,400 properties
Ventas	losing to	Ventas senior housing same-store NOI +15.4% YoY through Q4 2025, market cap ~$40.31B
Alexandria Real Estate	gaining on	Alexandria posted Q3 2025 net loss of $234.9M and occupancy fall to 90.6%, while Healthpeak expands lab bets
Janus Living	contesting	Healthpeak's own 2026 spin-off now competes in senior housing while paying Healthpeak a $10M annual management fee

Questions people ask

Is Healthpeak Properties profitable in 2026?: Yes. Healthpeak reported Q1 2026 revenue of $752.95 million, up 7.1% year over year, beating consensus of $694.59 million, with EPS of $0.45 versus $0.43 expected, as of May 5, 2026.
Could AI replace Healthpeak Properties' business?: No. Healthpeak owns physical real estate like hospital-affiliated medical buildings and lab campuses that AI cannot disintermediate. AI may only trim back-office finance and analytics roles; entitlements and tenant relationships remain untouched as of 2026.
Who is Healthpeak Properties' biggest competitor?: Welltower, with a market cap around $165.6 billion as of July 2026, dwarfs Healthpeak's $15.4 billion. Ventas (~$40.3 billion) is a closer strategic peer, and Alexandria competes directly in life science real estate.
Who owns Healthpeak Properties?: Healthpeak is fully public on the NYSE under ticker DOC, with no controlling parent. Institutional holders dominate, such as Vanguard Real Estate Index Fund at roughly 4.29% as of August 31, 2025; corporate insiders own only about 0.23%.
What happened to HCP Inc, the old name for Healthpeak?: HCP, Inc. renamed itself Healthpeak Properties and changed its ticker from HCP to PEAK in November 2019, then switched again to DOC in March 2024 after closing an all-stock merger with Physicians Realty Trust worth about $21 billion.
Is Healthpeak's life science real estate bet risky?: Yes, near-term. Healthpeak bought a $600 million South San Francisco lab campus in January 2026 at only 60% occupancy, while Bay Area lab vacancy sat at 39.8% in Q3 2025 and peer Alexandria posted a $234.9 million quarterly net loss.

Timeline

2026-07-22Formed $2.1 billion outpatient medical JV with Brookfield, 86 properties, 95% leased, Healthpeak holds 51% stake
2026-07-17Stock up 36 to 40% YTD, dividend yield around 5.4 to 5.6%
2026-06-15Confirmed S&P 500 status; announced Q2 2026 earnings release date
2026-06-01$650 million senior note at 3.5% matured, creating 2H26 interest expense headwind
2026-05-05Q1 2026 revenue $752.95 million, beat consensus, EPS $0.45 vs $0.43 expected
2026-05-04Raised FY2026 Nareit FFO/share guidance to $1.70 to $1.74 after Janus Living IPO completion
2026-03-30Janus Living senior housing REIT IPO closed, raising about $878 to $880 million net proceeds
2026-01-12Announced $925 million transaction activity including $600 million South San Francisco lab campus purchase
2026-01-06Announced formation of Janus Living as pure play RIDEA structured senior housing REIT
2024-03-29Closed ~$21 billion all-stock merger with Physicians Realty Trust, adopting DOC ticker

Revision history

24 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

AECOM PulteGroup Taylor Morrison Home